0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Effects of Acute and Chronic 17-β-Estradiol Administration on Rhombencephalic, Pineal and Pituitary Catecholamine Levels in Ovariectomized Rats

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the intermediate-posterior lobe of the pituitary gland there was a 2-fold increase in both dopamine and norepinephrine concentrations 12 h following estradiol injection to ovariectomized rats. Similar, but smaller, increases in dopamine levels were noted 24 h after injection of estradiol and following chronic estradiol treatment, as well as in norepinephrine levels 24 h after estradiol. In contrast, the dopamine content of anterior pituitary decreased following estradiol treatment. Epinephrine levels were not changed in the pituitary gland. No changes in four discrete brain stem regions or pineal gland catecholamine concentrations, with the exception of a small increase in dopamine concentration in the A2 area, were observed following either acute or chronic estradiol administration. Our results suggest that estrogens can selectively modulate catecholamine metabolism in the anterior and intermediate-posterior lobes of the pituitary gland.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1982
          1982
          26 March 2008
          : 35
          : 2
          : 123-127
          Affiliations
          Section on Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md., USA
          Article
          123366 Neuroendocrinology 1982;35:123–127
          10.1159/000123366
          7133317
          © 1982 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Original Paper

          Comments

          Comment on this article